Joined Jan 27, 2008
7,297 Blog Posts

Market Ripe To Squeeze; Watch For Runners

In a runaway market such as this, it makes sense to revisit the old faithful runner screen inside Exodus. This particular screen looks for stocks on the move that have a high short percentage. Think $TSLA.

This has been a go-to screen in frothy markets and helped me find $CLVS in the chat for a nice 8% day-trade.

Members of the Exodus platform can bookmark the runner screen HERE. For those not inside our premium service, have no fear, today’s results have been imported to finviz for your viewing pleasure: CLICK HERE FOR CHARTS

Tickers on watch include: X, RRC, OAS, CLVS, CERS, KBH, DDD, IRBT, JKS.

Remember, these are names people are betting against. Should the market get hit, expect these names to follow along with the market. $X is giving us a low risk setup against the recent low @ 8.96. I’ll be looking for a trade there.

Members, make sure to refresh the runner screen in the morning, there will be more.


Comments »

Tesla In Flight To a $1,000 Share Price

What a thing of beauty:


Millionaires are being made right now thanks to stubborn short sellers, and a man on a mission. You got to love these parabolic moves.


The FOMO was real on Monday:


With moves like that it’s no secret that $TSLA landed on top of the momentum scan to start the week. The only question now becomes how long until we hit $1000? Congrats Tesla bulls, and Raul! What a way to start February.

Here is the rest of Monday’s momentum scan: CLICK HERE FOR CHARTS. I have my eye on UBER, SPCE, BILI, PTON, SE, LULU, & of course the coronavirus.

Godspeed all.

Comments »

$VIR CEO Confident They Can Make A Vaccine For The Wuhan Coronavirus

Apparently the Coronavirus is no match for VIR Biotechnology. In the video below, the CEO of $VIR explains how they have been very successful in the past with Ebola and Zika. He also notes that his company has been anticipating the next coronavirus and have isolated antibodies from both SARS & MERS, two previous coronaviruses.

Dr. George Scangos, CEO, states that early data suggests the Wuhan coronavirus is considerably more infectious than SARS, however less lethal. He then goes on to say the Flu is no match for his company. See video below:

Comments »

Apple Crushes Earnings; The Corona Virus Is Not A Threat; And The Bull Continues To Run

The numbers coming out of $AAPL are downright astonishing, and a reminder of why we all should own extreme performers like AAPL. I myself do not currently have a position in the name, but I do own 1 share. It is an original $AAPL certificate that I received as a gift from my mother upon graduating college. I believe she paid $100 for a wooden frame and the stock certificate from the site Give-A-share. Since the 2006 gift, the stock has split and I now own a grand total of 7 shares. Balling!

Looking back on it, I wish I would have spent every dime that went into my retirement account on shares of AAPL. That said, will I buy $AAPL up here at a 1.4-5 Trillion valuation? I won’t.

Futures are green, and the bulls are back thanks to Apple not disappointing the street. It also appears that the Coronavirus has been blown out of proportion and that the threat to the US is low:

I doubt we have seen the end of this plague, but the market disagrees for now. It was a big red day for the virus stocks, but I will still be monitoring the likes of $LAKE, $NVAX, $NNVC, $CODX, & $LLIT.

As for Tuesday’s momentum, here were some of the top names sorted by Market Cap:

From the screen above $SQ is my favorite. The stock gave us a powerful breakout today, and should be bought on dips (I’m talking to myself). For those interested in today’s full momentum screen: CLICK HERE FOR CHARTS.

Comments »

Coronavirus Stocks To Buy When An Outbreak Occurs; Continued….

This is a follow up to my previous post which can be found HERE.

Again, this post is more for myself than it is for you the reader. A post I can come back to reference during the next pandemic crisis. Below, are the tickers I missed coming into the new week. All of which are very speculative in nature and relating to the new coronavirus in Wuhan. If you play any of the tickers below please make sure to have stops in place.

CBLI – Cleveland BioLabs, Inc., a biopharmaceutical company, focuses on developing pharmaceuticals designed to address diseases with unmet medical need.

Note: CBLI neither has any coronavirus drug or vaccine in its pipeline nor an experimental one targeting the deadly disease, but has an adjuvant vaccine candidate codenamed SA-701 in early-stage of development. Vaccine adjuvants are chemical substances that may be added to vaccines to boost the immune system. This nano-cap stock was up 200% on a link to this info.


AEMD – Aethlon Medical, Inc., a medical device company, focuses on creating devices for the treatment of cancer, infectious diseases, and other life-threatening conditions. It develops Aethlon Hemopurifier, a medical device that targets the elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression.

This one traded the entire float today and is a day traders dream. We caught shares early on this morning inside Exodus.


CDTX – Cidara Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of novel anti-infectives for the treatment of various diseases.

Note: Cantor Fitzgerald Stays Overweight, $8 Tgt On Cidara Therapeutics Believes ‘coronavirus brings CDTX’s Cloudbreak Antiviral Fc Conjugates (AVC) into the spotlight. The company is developing a universal flu vaccine and the data thus far has been impressive


VIVO – Meridian Bioscience, Inc., a life science company, develops, manufactures, and distributes diagnostic test kits primarily for various gastrointestinal, viral, respiratory, and parasitic infectious diseases worldwide.

Note: News hit the wire that certain diagnostic companies and labs in China have engaged the company to use its product to develop assyas.


Free free to leave any tickers I left out in the comment section.

Comments »

Coronavirus Stocks To Buy When An Outbreak Occurs

This post is more for me than it is for you, and in no way a recommendation to buy these stocks. It is my journal listing of stocks that are moving on volume on the latest Wuhan Coronavirus scare. What do we know so far? Very little as it seems many are keeping this thing under wraps. However, more details are pointing to a more significant threat.

It’s hard to determine what is fact and fiction in this new age of “Fake News” , but here is the current Outbreak map and the RO number:


Stocks seeing activity due to the outbreak are as follows (Highest price to lowest price): AZN, MRNA, VIR, LAKE, NNVC, NVAX, APT, ICCC, CERS, INO, AHPI, BCRX, AEMD, CODX, CBLI, LLIT

AZN – engages in the discovery, development, and commercialization of prescription medicines for the treatment of respiratory, inflammation, autoimmune, cardiovascular, metabolic, oncology, infection, neuroscience, and gastrointestinal diseases worldwide

AstraZeneca CEO Pascal Soriot told CNBC. “We have a very large presence in China, and are the number one pharmaceutical company there, we employ 16,000 people — so as you would imagine it matters to us, we really care a lot and we’ll monitor this, but it really looks like it’s contained for the time being.”


MRNA – Creating a new category of transformative medicines based on mRNA to improve the lives of patients. From the beginning, we designed our strategy and operations to realize the full potential value and impact of mRNA over a long time horizon across a broad array of human diseases

Note: “MRNA has received new funding from vaccine alliance CEPI to accelerate its work on a coronavirus vaccine, and it has joined forces with the Coalition for Epidemic Preparedness Innovations on a vaccine approach.”


VIR – a clinical-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases.

Note: “$VIR holds a portfolio that includes an antibody for another coronavirus strain, but management is testing to determine efficacy on the Wuhan strain.”


LAKE – The company offers limited use/disposable protective clothing, such as coveralls, lab coats, shirts, pants, hoods, aprons, sleeves, smocks, and shoe covers; high-end chemical protective suits to provide protection from highly concentrated and hazardous chemical and biological toxins; and fire fighting and heat protective apparel, which is used for the maintenance of high temperature equipment, and for military and airport crash and rescue teams.


NNVC – NanoViricides, Inc., a nano-biopharmaceutical company, discovers, develops, and commercializes therapeutics for the treatment of viral infections. The company is developing anti-influenza drug candidates at pre-clinical and advanced pre-clinical stage, which include two FluCide drugs comprising NV-INF-2, an oral anti-influenza drug and NV-INF-1, an injectable anti-influenza drug for novel strain of H7N9, Bird Flu H5N1, and other Highly Pathogenic Influenzas

Note: The company announced a secondary offering after the first day spike. Investors gobbled it up, buying the dip like madmen.


NVAX – Novavax, Inc., a clinical-stage vaccine company, focuses on discovering, developing, and commercializing recombinant nanoparticle vaccines and adjuvants. The company also has pre-clinical stage programs for various infectious diseases, including the Middle East respiratory syndrome coronavirus; and develops technology for the production of immune stimulating saponin-based adjuvants.

Note: Like NNVC, the company has already announced a secondary offering and the stock is recovering from the news.


APT – engages in developing, manufacturing, and marketing a line of disposable protective apparel, building supply products, and infection control products in the United States and internationally.

Note: APT is LAKE’s little cousin. They almost always move in tandem with each other.


ICCC –  is involved in the development of Mast Out, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows; and treatments that prevent E. coli K99 and bovine coronavirus, as well as calf scours caused by enteric pathogens.


CERS – Its INTERCEPT Blood System is based on its proprietary technology for controlling biological replication; and targets and inactivates blood-borne pathogens, including viruses, bacteria, and parasites, as well as harmful white blood cells, while preserving the therapeutic properties of platelet, plasma, and red blood cell transfusion products.

NOTE: Cowen notes that it is encouraged by prior data suggesting that Cerus’s Intercept could be an effective tool against the Coronavirus family.


INO – a clinical stage biopharmaceutical company, develops active DNA immunotherapies and vaccines in combination with proprietary electroporation delivery devices to prevent and treat cancers and infectious diseases.

NOTE: “INO is developing a vaccine to treat the MERS strain of coronavirus, management may be able to contribute its research toward the Wuhan coronavirus effort.”


AHPI – Allied Healthcare Products, Inc. engages in the manufacture, marketing, and distribution of various respiratory products for a range of hospital and alternate site settings to the health care industry in the United States, Europe, Canada, Latin America, the Middle East, the Far East, and internationally.

Note: A sleeper Coronavirus play that popped up after traders started searching for companies that had products to treat respiratory problems. The stock was halted on Friday for a few mintues as traders rushed to buy up shares.


BCRX – a biotechnology company, designs, optimizes, and develops small molecule drugs that block key enzymes involved in the pathogenesis of diseases

NOTE: galidesivir is in a Phase 1 study for a range of viruses, including coronaviruses. The early stage of development may prohibit material contribution in the immediate outbreak, but BioCryst may be able to lend some useful data.


AEMD – a medical device company, focuses on creating devices for the treatment of cancer, infectious diseases, and other life-threatening conditions. It develops Aethlon Hemopurifier, a medical device that targets the elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression.


CODX – is a molecular diagnostics company that has developed and intends to manufacture and sell reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules (DNA or RNA), and to sell diagnostic equipment from other manufacturers as self-contained lab systems.

NOTE: Similar to NNVC & NVAX, the company issued a secondary offering right after the one day spike. Investors gobbled up the dip quick on Friday.


CBLI – a biopharmaceutical company, focuses on developing pharmaceuticals designed to address diseases with unmet medical need.


LLIT – offers medical devices, including medical ventilators, general hospital products, medical compressors, and wireless medical products, as well as related supporting products.

NOTE: Similar to AHPI, the stock was halted serval times as traders went down the food chain for respirator products.


Feel free to add tickers to this list in the comment section.

Comments »